about
Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.Substrate kinetics in patients with disorders of skeletal muscle metabolism.[Juvenile asymmetrical segmental spinal muscular atrophy].Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency.Patients with severe muscle wasting are prone to develop hypoglycemia during fasting.Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency.Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.Aerobic training in persons who have recovered from juvenile dermatomyositis.Fat metabolism during exercise in patients with mitochondrial disease.Fat metabolism during exercise in patients with McArdle disease.Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency.Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?Impaired energy metabolism and abnormal muscle histology in mut- methylmalonic aciduria.Aerobic fitness after JDM--a long-term follow-up study.Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease)Protein-carbohydrate supplements improve muscle protein balance in muscular dystrophy patients after endurance exercise: a placebo-controlled crossover studyLactate metabolism during exercise in patients with mitochondrial myopathyEndocrine function over time in patients with myotonic dystrophy type 1No effect of bezafibrate in patients with CPTII and VLCAD deficiencies[Incomplete Kawasaki syndrome with a coronary artery aneurysm in an infant]Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophyPatients With Medium-Chain Acyl–Coenzyme A Dehydrogenase Deficiency Have Impaired Oxidation of Fat During Exercise but No Effect ofl-Carnitine SupplementationMuscle phenotype in patients with myotonic dystrophy type 1Fat and carbohydrate metabolism during exercise in late-onset Pompe diseaseEndocrine function in 97 patients with myotonic dystrophy type 1Blocked Muscle Fat Oxidation During Exercise in Neutral Lipid Storage DiseaseMuscle phosphorylase kinase deficiency: A neutral metabolic variant or a disease?EFFECTS OF IV GLUCOSE AND ORAL MEDIUM-CHAIN TRIGLYCERIDE IN PATIENTS WITH VLCAD DEFICIENCYMuscle structural changes in mitochondrial myopathy relate to genotype
P50
Q37658358-5C21045B-CF91-4271-B2B0-DBA6D447ADB0Q40097488-B9DD23ED-97D1-4B07-A133-4274539A7F89Q44135450-50FCB699-C366-4B6A-A6B6-B1F8B6370835Q44562271-A375F238-87AF-40CD-949A-2376A38F5160Q44616607-C852C863-DAD4-4F55-B8B2-4A11D752DF49Q45006691-2500C58D-07D6-4127-9CF5-A2B5AB5B3A4BQ45204457-E822019A-5B54-45CB-8FF4-6A0CB41EA296Q45902190-91831DAC-4738-44DF-93B3-03B5BB464E6CQ46094204-E2EEDC95-F9AE-4288-A8D0-8F072DE46CA5Q46112058-0E41D162-BFF2-49DB-91E2-B273323C3D85Q46527842-025F27BD-AC01-4B8B-B3C9-254CD3334028Q46653825-B8285BD5-A22C-413E-BDFB-F8448F26C392Q46722573-0C872170-1D2D-41FC-922E-3BFA35F9C79BQ46892973-AEC71591-E883-4FD5-971F-74EF718DF87AQ58818126-E611D37F-E6F0-43B4-AA5C-06B3D1F8405EQ58818134-3B294F7E-2E1B-46AE-A9EB-0B1171538E39Q58818165-B9B5230B-AFB3-49FA-96CB-DED9578CE727Q60772295-0AA8FBD0-A834-43F3-8502-5933D29E2928Q61805222-6D7DF07C-5794-4A89-924B-B259E09FE678Q61805234-00390F4E-9003-4AB6-A43E-4FEA4F9D56C8Q61805248-318EAE92-DC2F-4C4E-B8A1-45C8DE62212DQ61805259-F47E14DD-9756-4773-A8B6-D965E3B4891EQ61805266-2A1D93DA-2A01-47B2-B48C-D9AFF89B4C7CQ61805275-A53D6A25-93A5-4AE4-BC4C-83E8B5EA8A54Q61805281-C6E715E1-91A2-4658-BC84-DFB8513637A2Q61805287-9571EF1F-D0B5-41B2-A1F3-7187C4FBFE69Q61805292-4824D8EC-4138-472C-97D9-77C1BCE6CCD5Q61805309-AC2F0B20-19D6-4B24-BD77-706D871E0856Q61805332-CEEB152A-FE39-4BB6-BD77-66363DE51239
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mette C Ørngreen
@ast
Mette C Ørngreen
@en
Mette C Ørngreen
@es
Mette C Ørngreen
@nl
Mette C Ørngreen
@sl
type
label
Mette C Ørngreen
@ast
Mette C Ørngreen
@en
Mette C Ørngreen
@es
Mette C Ørngreen
@nl
Mette C Ørngreen
@sl
prefLabel
Mette C Ørngreen
@ast
Mette C Ørngreen
@en
Mette C Ørngreen
@es
Mette C Ørngreen
@nl
Mette C Ørngreen
@sl
P106
P21
P31
P496
0000-0002-2991-6309
P569
2000-01-01T00:00:00Z